|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.1 USD | +1.22% |
|
-6.02% | +5.46% |
| Apr. 15 | Global markets live: Goldman Sachs, Apple, Salesforce, Boeing Tesla... |  |
| Apr. 15 | Market outlook is uncertain, but optimism prevails | |
May 4 (Reuters) - Moderna Inc on Wednesday maintained the full-year sales forecast for its COVID-19 vaccine at $21 billion, as cases fall and demand slackens after countries rushed to secure shots last year. (Reporting by Manas Mishra in Bengaluru; Editing by Saumyadeb Chakrabarty)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.46% | 39.77B | |
| +48.77% | 42.16B | |
| -0.14% | 42.07B | |
| -11.36% | 26.68B | |
| +4.36% | 24.68B | |
| -23.11% | 18.68B | |
| -1.25% | 12.11B | |
| +26.19% | 11.99B | |
| +5.75% | 11.06B | |
| -16.82% | 10.3B |
MODERNA, INC. 
